Wed, Aug 18
|Online Zoom Webinar
MedLabs InnoTalk Series: Trade Controls and CFIUS issues in Life Science-EPISODE ONE
Register and learn about CFIUS, trade regulations, and the impact on the Life Science Industry for both startups and investors.
Time & Location
Aug 18, 2021, 11:00 AM – 12:00 PM
Online Zoom Webinar
About the Event
About MedLabs InnoTalk Series
MedLabs InnoTalk Series gives MedLabs Accelerator and community direct contact with the top trends and ideas in the healthcare industry and with people who are leading the innovations in healthcare investment, entrepreneurship, and research. The series events are open to the public for free, with invitations sent to all our members, mentors, and corporate partners.
About This Event
On January 13, 2020, the U.S. Department of the Treasury released final regulations implementing the updates to the foreign investment review process of the Committee on Foreign Investment in the United States (“CFIUS”) contained in the Foreign Investment Risk Review Modernization Act of 2018. These regulations took effect on Feb 13, 2020, significantly increasing the CFIUS’ influence over national security reviews of investments. The Act focuses specifically on companies with advanced technologies and access to sensitive data.
What does this mean for businesses and investors in the life sciences and biotech sectors? What risks will need to be mitigated? What investments will have increased scrutiny under CFIUS?
In this two-episode InnoTalk Event, we are pleased to invite Judith Allison Lee, Co-Chair at the International Trade Regulation and Compliance Practice Group and Partner at Gibson, Dunn & Crutcher LLP, and Carl Valenstein, Partner at Morgan, Lewis & Bockius.
Our two special guests will address the topic in two different angles, covering perspectives from both startup companies and international investors in the life science industry. Our webinar series will guide you through the details of FIRRMA as well as the intention of the rules, how they are impacting investors and companies, and what to expect in the future.
*We highly recommend you attend both episodes for a full understanding of the CFIUS and trade controls issues in life science.
EPISODE ONE
Trade Controls in Life Sciences - How Startups Managing the Sanctions, Export Controls and CFIUS Risks
Date: August 18th, 11AM-12PM PDT, 2PM-3PM EDT
Location: Online Zoom Webinar
Here is what you will learn:
- Definitions of Economic Sanctions, Sanctions, Export Controls and CFIUS Risks
- How trade controls and regulations impact global business
- Whether a company is ready to answer investors’ questions with respect to national security concerns that may be implicated by its business in the event that foreign investors acquire a minority or controlling interest.
- How to identify whether a product/technology is potentially covered by an export license requirement
- Advices to U.S. companies that operate within the biotechnology and life science industries
About the Speaker
Judith Alison Lee
Co-Chair at the International Trade Regulation and Compliance Practice Group
Partner at Gibson, Dunn & Crutcher, LLP
Judith Alison Lee is Co-Chair of the International Trade Regulation and Compliance Practice Group and a partner in Gibson, Dunn & Crutcher, LLP’s Washington, DC office. Her areas of expertise include: OFAC, FCPA, export controls, CFIUS, and blockchain and cryptocurrency issues. Ms. Lee has been consistently selected by Chambers Global-Business as a leading lawyer for USA International Trade in Export Controls and Economic Sanctions, and by Chambers and Partners as a leading International Trade Lawyer in Chambers USA: America's Leading Lawyers for Business Guide. She is former Co-Chair of the IBA’s Export Controls, Sanctions and Anti-Corruption Subcommittee, and former Co-Chair of the ABA’s Export Controls and Embargoes Committee.
EPISODE TWO
CFIUS issues in Life Science Investment and Venture Capital Transactions
Date: September 1st, 10AM-11AM PDT, 1PM-2PM EDT
Location: Online Zoom Webinar
Here is what you will learn:
- CFIUS due diligence and standard contractual provisions from the company and investor perspectives
- Increased risk of CFIUS reviews of non-notified transactions
- Difference between mandatory and voluntary CFIUS filings
- Key issues for life sciences companies
- Key planning techniques for not having a “covered transaction”
About the Speaker
Carl Valenstein
Partner at Morgan, Lewis & Bockius
Carl Valenstein focuses his practice on domestic and international corporate and securities matters, mergers and acquisitions, project development, and transactional finance. He counsels extensively in the life science, telecom/electronics, and maritime industries, and has worked broadly in Latin America, the Caribbean, Europe, Africa, Asia, and the Middle East. He previously served as co-chair of the International Section of the Boston Bar Association and co-chairs the firm’s environmental, social, and governance (ESG) and sustainable business and Cuba initiatives. Carl is the leader of the Boston office corporate and business transactions practice.
Event Host and Partners
MedLabs Healthcare Accelerator
MedLabs is established and run by ZGC Capital and Global Health Impact Network, We have 60+ mentors, corporate partners in more than 6 countries. It’s our mission to connect the best healthcare startups in Silicon Valley with investors, mentors, and corporate partners around the world to build a Healthcare Innovation Ecosystem.
During the three-month program, MedLabs offers healthcare startups several key resources: the opportunity to receive a $100,000 #funding provided by Global Health Impact Fund, access to capital, dedicated #mentorship, #workshop training, global business partnerships, a huge #clinical network, private investor meeting, and #workspace in Silicon Valley and Boston.
About ZGC Capital Corporation
ZGC is a multi-functional platform dedicated to accelerating the world’s innovative business by providing dynamic space services and integrated business solutions for startups, entrepreneurs, investors, corporate intrapreneurs, and industry evolution seekers.
Headquartered in Silicon Valley, we started our journey in 2014, with a mission to bridge top-tiered resources between the world’s top innovation hubs. Our two centers, located in the heart of Silicon Valley and Boston-Cambridge, provide an internationally collaborative environment for tech startups, venture capitals, and cross-border organizations to exchange, create, and innovate.
About Global Health Impact Network
Global Health Impact Network is building a robust global health professional driven network of communities across professions and specialties. GHIN is the place where Healthcare Professionals collaborate on the future of Digital Health Innovation. GHIN is a community of like-minded healthcare professionals who share a common vision “empower healthcare professionals to actively participate in shaping the evolving digital healthcare revolution."
www.globalhealthimpactnetwork.net
About LEAP
LEAP (Life-science Entrepreneurship and Plus) is a 501(c)(3) non-profit organization based in Silicon Valley, with the mission to promote innovation, collaboration and entrepreneurship in life sciences and related fields.
About eChinaHealth
eChinaHealth is an integrated media for China healthcare and pharmaceutical. Its services include digital platform and media, conferences and events, data and consulting, and social network and community. “eChinaHealth Review” provides timely and professional international healthcare and medical news to Chinese doctors and professionals. eChinaHealth is officially authorized by the American Society of Clinical Oncology (ASCO) to organize “ASCO Direct China” conferences; and by the American Society of Endocrinology (ES) to organize “ENDO Direct China” conferences, in an effort to provide Chinese doctors’ access to the most cutting-edge research discussed at global healthcare meetings.